Literature DB >> 2256739

Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis.

L R Fisher1, M I Cawley, S T Holgate.   

Abstract

Thirty three patients with definite ankylosing spondylitis (AS) were examined to establish the relation between restriction of chest expansion, limitation of lung function, and working capacity or exercise tolerance. As in previous studies there was a significant association between chest expansion and lung vital capacity. There was also a significant association between vital capacity and exercise tolerance as measured by a subject's maximum oxygen capacity (VO2max). Both vital capacity and VO2max were expressed as a percentage of predicted normal values using patients' height before disease. In this study chest expansion did not have a significant effect on exercise tolerance. The results suggested that patients who took a modest amount of exercise regularly could maintain a satisfactory work capacity despite very restricted spinal and chest wall mobility. It is recommended that greater emphasis should be given to encouraging patients with AS to maintain cardiorespiratory fitness as well as spinal mobility.

Entities:  

Mesh:

Year:  1990        PMID: 2256739      PMCID: PMC1004263          DOI: 10.1136/ard.49.11.921

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Measurement of spinal mobility: a comparison of three methods.

Authors:  P M Reynolds
Journal:  Rheumatol Rehabil       Date:  1975-08

2.  The thorax in ankylosing spondylitis.

Authors:  F D HART; A BOGDANOVITCH; W D NICHOL
Journal:  Ann Rheum Dis       Date:  1950-06       Impact factor: 19.103

3.  Pleuropulmonary manifestations of ankylosing spondylitis.

Authors:  E Rosenow; C V Strimlan; J R Muhm; R H Ferguson
Journal:  Mayo Clin Proc       Date:  1977-10       Impact factor: 7.616

4.  Pulmonary involvement in ankylosing spondylitis.

Authors:  N Feltelius; H Hedenström; G Hillerdal; R Hällgren
Journal:  Ann Rheum Dis       Date:  1986-09       Impact factor: 19.103

Review 5.  Exercise testing in clinical medicine.

Authors:  S G Spiro
Journal:  Br J Dis Chest       Date:  1977-07

6.  Inspiratory muscle fatigue as a factor limiting exercise.

Authors:  A Grassino; D Gross; P T Macklem; C Roussos; G Zagelbaum
Journal:  Bull Eur Physiopathol Respir       Date:  1979 Jan-Feb

7.  Spondylometry in a normal population and in ankylosing spondylitis.

Authors:  R D Sturrock; J A Wojtulewski; F D Hart
Journal:  Rheumatol Rehabil       Date:  1973-08

8.  Diaphragmatic contribution to ventilation in patients with ankylosing spondylitis.

Authors:  W T Josenhans; C S Wang; G Josenhans; J F Woodbury
Journal:  Respiration       Date:  1971       Impact factor: 3.580

9.  An objective clinical study of chest expansion.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

10.  Cardiorespiratory consequences of unfused idiopathic scoliosis.

Authors:  M A Branthwaite
Journal:  Br J Dis Chest       Date:  1986-10
View more
  22 in total

1.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

2.  Intra-tester and inter-tester reliability of chest expansion measurement in clients with ankylosing spondylitis and healthy individuals.

Authors:  Jagannath Sharma; Hideaki Senjyu; Linda Williams; Colin White
Journal:  J Jpn Phys Ther Assoc       Date:  2004

3.  The efficiency of inspiratory muscle training in patients with ankylosing spondylitis.

Authors:  Bilge Basakci Calik; Elif Gur Kabul; Harun Taskın; Orcin Telli Atalay; Ummuhan Bas Aslan; Murat Tascı; Fahrettin Bıcakcı; Ali Ihsan Yıldız
Journal:  Rheumatol Int       Date:  2018-06-25       Impact factor: 2.631

4.  Evaluation of the internal oblique, external oblique, and transversus abdominalis muscles in patients with ankylosing spondylitis: an ultrasonographic study.

Authors:  Ahmet Üşen; Banu Kuran; Figen Yılmaz; Neşe Aksu; Cem Erçalık
Journal:  Clin Rheumatol       Date:  2017-09-10       Impact factor: 2.980

5.  Diaphragmatic movements in ankylosing spondylitis patients and their association with clinical factors: an ultrasonographic study.

Authors:  Ercüment Ünlü; Ömer Nuri Pamuk; Burak Erer; Salim Dönmez; Necati Çakir
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 6.  Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice.

Authors:  Cecilia Mercieca; Irene E van der Horst-Bruinsma; Andrew A Borg
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

7.  Pulmonary function in ankylosing spondylitis: association with clinical variables.

Authors:  A J L Brambila-Tapia; A D Rocha-Muñoz; L Gonzalez-Lopez; M Vázquez-Del-Mercado; M Salazar-Páramo; I P Dávalos-Rodríguez; L De la Cerda-Trujillo; M L Diaz-Toscano; P Hernandez-Cuervo; V Diaz-Rizo; D Sanchez-Mosco; J C Vazquez-Jimenez; E G Cardona-Muñoz; J I Gamez-Nava
Journal:  Rheumatol Int       Date:  2013-03-30       Impact factor: 2.631

8.  Effects of Pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a randomized controlled trial.

Authors:  Mihaela Oana Roşu; Ionuţ Ţopa; Rodica Chirieac; Codrina Ancuta
Journal:  Rheumatol Int       Date:  2013-09-26       Impact factor: 2.631

9.  Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis.

Authors:  Hyungpil Cho; Taikon Kim; Tae-Hwan Kim; Seunghun Lee; Kyu Hoon Lee
Journal:  Ann Rehabil Med       Date:  2013-10-29

10.  Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis.

Authors:  Uzunca Kaan; Ozdemir Ferda
Journal:  Rheumatol Int       Date:  2004-02-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.